Equity Overview
Price & Market Data
Price: $6.37
Daily Change: -$0.01 / 0.16%
Range: $5.97 - $6.40
Market Cap: $2,829,764,096
Volume: 4,144
Performance Metrics
1 Week: -27.34%
1 Month: -33.68%
3 Months: -30.62%
6 Months: -36.89%
1 Year: -42.83%
YTD: -31.89%
Company Details
Employees: 9350
Sector: Health technology
Industry: Pharmaceuticals: major
Country: South Africa
Details
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.